ClinVar Miner

Submissions for variant NM_000179.3(MSH6):c.3554_3556+2del

dbSNP: rs2104510085
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Myriad Genetics, Inc. RCV003449999 SCV004189313 likely pathogenic Lynch syndrome 5 2023-08-24 criteria provided, single submitter clinical testing This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function.
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001356348 SCV001551492 pathogenic Carcinoma of colon no assertion criteria provided clinical testing The MSH6 c.3554_3556+2delCAGGT variant was not identified in the literature nor was it identified in dbSNP, Clinvitae database, COSMIC, Mismatch Repair Genes Variant Database, MMR Gene Unclassified Variants Database, InSiGHT Colon Cancer Gene Variant Database (LOVD), Zhejiang Colon Cancer Database (LOVD), ClinVar database, GeneInsight-COGR database, UMD, the 1000 Genomes Project, NHLBI GO Exome Sequencing Project, and the Exome Aggregation Consortium database (August 8, 2016). The c.3554_3556+2delCAGGT variant is located in the 5' splice donor region deleting the last three bases of the exon and first 2 bases of the intron. This position has been shown to be part of the splicing consensus sequence and invariant +1 and +2 positions, and variants involving this position sometimes affect splicing. In silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict the abolishment of the 5' splice site in this region, shifting it 5 base pairs upstream; however, this information is not predictive enough to assume pathogenicity. Protein-level nomenclature for this variant was predicted as p.Ser1185_Gly1186delinsCys. In summary, based on the above information, this variant meets our laboratory’s criteria to be classified as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.